Sarcoidosis vasculitis and diffuse lung diseases
Published: 01-12-2009
Editorial
Antioxidant therapy for idiopathic pulmonary fibrosis. A promising therapeutic prospect
Abstract 39 | PDF (Italian) Downloads 44Page 83-84
Original Articles: Clinical Research
Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry
Abstract 66 | PDF (Italian) Downloads 45Page 85-91
Fatigue in sarcoidosis: American versus Dutch patients
Abstract 64 | PDF (Italian) Downloads 40Page 92-97
Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study
Abstract 37 | PDF (Italian) Downloads 37Page 98-109
Inhaled iloprost for sarcoidosis associated pulmonary hypertension
Abstract 81 | PDF (Italian) Downloads 81Page 110-120
Steroid-Sparing effects of pentoxifylline in pulmonary sarcoidosis
Abstract 55 | PDF (Italian) Downloads 50Page 121-131
Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia
Abstract 77 | PDF (Italian) Downloads 49Page 132-138
Original Articles: Laboratory Research
Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis
Abstract 52 | PDF (Italian) Downloads 37Page 139-146
N-acetylcysteine inhibits TNF-a, sTNFR, and TGF-b1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro
Abstract 39 | PDF (Italian) Downloads 180Page 147-154
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis
Abstract 114 | PDF (Italian) Downloads 46Page 155-161
Case Reports
Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis
Abstract 116 | PDF (Italian) Downloads 35Page 162-166
Letter to Editor
Lupus pernio: a tale of four characters in search of a malady
Abstract 166 | PDF (Italian) Downloads 38Page 167-171